Literature DB >> 20610543

Cancer statistics, 2010.

Ahmedin Jemal1, Rebecca Siegel, Jiaquan Xu, Elizabeth Ward.   

Abstract

Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data regarding cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,529,560 new cancer cases and 569,490 deaths from cancer are projected to occur in the United States in 2010. Overall cancer incidence rates decreased in the most recent time period in both men (1.3% per year from 2000 to 2006) and women (0.5% per year from 1998 to 2006), largely due to decreases in the 3 major cancer sites in men (lung, prostate, and colon and rectum [colorectum]) and 2 major cancer sites in women (breast and colorectum). This decrease occurred in all racial/ethnic groups in both men and women with the exception of American Indian/Alaska Native women, in whom rates were stable. Among men, death rates for all races combined decreased by 21.0% between 1990 and 2006, with decreases in lung, prostate, and colorectal cancer rates accounting for nearly 80% of the total decrease. Among women, overall cancer death rates between 1991 and 2006 decreased by 12.3%, with decreases in breast and colorectal cancer rates accounting for 60% of the total decrease. The reduction in the overall cancer death rates translates to the avoidance of approximately 767,000 deaths from cancer over the 16-year period. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, geographic area, and calendar year. Although progress has been made in reducing incidence and mortality rates and improving survival, cancer still accounts for more deaths than heart disease in persons younger than 85 years. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population and by supporting new discoveries in cancer prevention, early detection, and treatment. Copyright 2010 American Cancer Society, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20610543     DOI: 10.3322/caac.20073

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  2000 in total

1.  A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.

Authors:  Jason A Willis; Sara H Olson; Irene Orlow; Semanti Mukherjee; Robert R McWilliams; Robert C Kurtz; Robert J Klein
Journal:  Clin Cancer Res       Date:  2012-06-04       Impact factor: 12.531

2.  AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.

Authors:  Melissa K Brunckhorst; Dimitry Lerner; Shaomeng Wang; Qin Yu
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

3.  A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer.

Authors:  J Rodríguez-Pascual; P Sha; E García-García; N V Rajeshkumar; E De Vicente; Y Quijano; A Cubillo; B Angulo; O Hernando; M Hidalgo
Journal:  Invest New Drugs       Date:  2012-06-07       Impact factor: 3.850

4.  Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Authors:  Shaofan Weng; Hua Wang; Weihong Chen; Matthew H Katz; Deyali Chatterjee; Jeffrey E Lee; Peter W Pisters; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

Review 5.  Headache in patients with cancer.

Authors:  Samuel A Goldlust; Jerome J Graber; Dana F Bossert; Edward K Avila
Journal:  Curr Pain Headache Rep       Date:  2010-12

6.  Transcriptional regulation of O-GlcNAc homeostasis is disrupted in pancreatic cancer.

Authors:  Kevin Qian; Simeng Wang; Minnie Fu; Jinfeng Zhou; Jay Prakash Singh; Min-Dian Li; Yunfan Yang; Kaisi Zhang; Jing Wu; Yongzhan Nie; Hai-Bin Ruan; Xiaoyong Yang
Journal:  J Biol Chem       Date:  2018-07-23       Impact factor: 5.157

7.  African american primary care physicians' prostate cancer screening practices.

Authors:  Louie E Ross; Ingrid J Hall
Journal:  J Prim Care Community Health       Date:  2013-10-17

Review 8.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?

Authors:  Erica T Warner; Rulla M Tamimi; Deborah A Boggs; Bernard Rosner; Lynn Rosenberg; Graham A Colditz; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2013-02-05       Impact factor: 2.506

10.  Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis.

Authors:  Yongchun Shen; Tao Wang; Ting Yang; Qianjing Hu; Chun Wan; Lei Chen; Fuqiang Wen
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.